3 ms·
> Under drug IPR rules no market price can exist for many drugs because they are single source. If you want to admit a market permit Indian generics into the US
by AnthonyMouse 8y ago
> Under drug IPR rules no market price can exist for many drugs because they are single source. If you want to admit a market permit Indian generics into the USA and watch prices tumble.
There is still a market price because the customer has an alternative. There is a second best drug. In the worst case (e.g. the only alternative is death), there is still a price because the drug company can't demand a billion dollars if the customer doesn't have a billion dollars.
The fact that we get into this position of no alternative but death is problematic, but it's also how the patent system is designed to work. If the drug didn't exist, you would die. If it does exist, you have the choice between death or bankruptcy. This is still not ideal, but it's better than the original situation, and eventually the drug patent expires.
There are a number of implementation failures with this, like public funding going to drug research that is subsequently patented, and a regulatory system that gives no one an incentive to do clinical trials for promising treatments they don't hold a patent on, and so on.
But the basic idea is not without merit. It costs a mint to do research and trials. If there isn't money in it then companies wouldn't do it. So if there is a patented drug which is the only thing that can save your life, would you rather have to file for bankruptcy paying for it, or have it not exist because we said they're not allowed to make enough money to get them to do the R&D to begin with? In some cases there isn't really a third option.
In principle you can have the government fund the research instead of depending on the market, and then not patent it so patients don't have to pay a lot. Which works fine when that finds the cure. But if it doesn't, do you still want the system that allows the market to find it as a backup, or not?
- cheschire 8y agoSo basically on top of dealing with the stress of a life threatening disease, you're suggesting that a family must either decide to watch a parent die, and maintain financial stability, or attempt to live and set the whole family back? That's definitely a perspective, I guess.
- thaumasiotes 8y ago> In the worst case (e.g. the only alternative is death), there is still a price because the drug company can't demand a billion dollars if the customer doesn't have a billion dollars. There's a much stricter limit than that. I keep seeing people say that you can charge as much money for lifesaving medical care as the patient has, and it's nonsense. That hypothetical patient is choosing between whatever remains of their life and leaving an inheritance of $1 billion. I guarantee you that the world is chock full of people who would kill themselves for $1 billion. Life insurance policies exclude suicide for a reason, and they pay tens of thousands of times less than that.
- simonh 8y agoQuite. Fortunately we can have our cake and eat it. We can, and do, have for-profit companies invest capital in expensive drug development. We can and do protect their investments for them with patents, and by shielding them from competition from generics for a period. In return we regulate the prices they can charge. That all seems fair and reasonable to me. The companies both benefit from and are constrained by regulation. They wouldn't exist without regulatory protection, so it's fair that it comes with a cost. In reality the question is what constitutes fair regulation, and that's something reasonable people can disagree on.
- AnthonyMouse 8y ago> In return we regulate the prices they can charge. And then you don't get the expensive drugs. Suppose there are 50,000 people with a fatal condition. Researching a cure and getting it approved would cost $5B. Therefore each person needs to pay at least $100,000, or there isn't enough money to fund the research. If you say they can only charge $10,000/patient, no cure. Whatever price you set as the max they can charge, that's the value you're assigning to a human life.
- Pharmakon 8y ago> In return we regulate the prices they can charge. And then you don't get the expensive drugs. Suppose there are 50,000 people with a fatal condition. Researching a cure and getting it approved would cost $5B. Therefore each person needs to pay at least $100,000, or there isn't enough money to fund the research. If you say they can only charge $10,000/patient, no cure. Whatever price you set as the max they can charge, that's the value you're assigning to a human life. With just a few minor word substitutions, what you just said could as easily be the speech a bank robber, trapped in the bank with a dozen hostages. If that $10,000 reflects the profit motive taken to an extreme rather than anything related to the cost of the drug, then it’s the company placing a number on human life. Specifically they’re saying, “It’s only worth our time if you pay us enough for us to 100x+ our margins.”
- AnthonyMouse 8y ago